The event is an "Glenmark Annual Investor Day 2026", comprising group and one-on-one meetings with analysts and institutional investors.
The event is scheduled for Tuesday, June 2nd, 2026. The specific time was not disclosed in the announcement.
The stated purpose of the event is a discussion based on "the financial and operational performance of the Company as published in the investor presentation/ Investor updates".
The company reference number for this disclosure is 11/26-27.
The mode of the meeting is Physical, and the venue is Mumbai.
Management participants and their designations were not provided in this specific intimation.
The company has stated that an investor presentation shall be made available before the event on the stock exchanges and on the company's website at www.glenmarkpharma.com.
The company has indicated compliance with SEBI LODR Regulations by stating the discussion will be based on already published information, implying that no unpublished price sensitive information (UPSI) will be shared.
Additional Notes Section
This is a formal regulatory intimation letter addressed to the National Stock Exchange of India Limited and BSE Limited.
The document explicitly states that the schedule is subject to change due to exigencies on the part of investors or the company.
No financial data, guidance, or strategic updates were disclosed in this announcement; it serves purely as a notice for the upcoming event.
The letter is digitally signed by Harish Kuber, the Company Secretary & Compliance Officer.
